Tobacco, Alcohol and Cancerization of the Oral Mucosa (TACO)

Registration Number
NCT06425146
Lead Sponsor
Centre Leon Berard
Brief Summary

The goal of this project is to describe somatic mutations of healthy oral mucosa from patients with oral squamous cell carcinoma (OSCC).

Detailed Description

Epidermoid carcinomas of upper aerodigestive tract are the 8th most common cancers in the world. Worldwide, this represents more than 500.000 cases per year and 20.000 cases per year in France (statistics 2018-2020). Among these cancers, oral squamous cell carcinoma (OSCC) are the most common location, leading to significant morbidity and mortality.
...

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • I1. Male or female aged 18 years or older at the date of signature of the informed consent to participate.
  • I2. Patient with histological diagnosis of epidermoid carcinomas of the oral cavity NB: All grades are eligible.
  • I3. Patient naive of any systemic anti-cancer treatment (radio- or chemotherapy).
  • I4. Patient able to understand, sign and date informed consent before the start of any study protocol procedure.
  • I5. Patient affiliated or covered by a medical insurance
Read More
Exclusion Criteria
  • E1. Patients at high risk of bleeding, such as those on anticoagulant or antiplatelet aggregant treatment, with clotting disorders or a history of severe bleeding in the two weeks prior to inclusion.
  • E2. Patient with lesions of all types on the mucosa of the cheek located on the opposite side of the area affected by an epidermoid carcinoma of the oral cavity which prevents painless removal of the healthy mucosa.
  • E3. Patient who had surgery for their epidermoid carcinoma of the oral cavity more than 6 months ago.
  • E4. Patient who uses cannabis.
  • E5. Patient with another active tumor or HPV-positive tumors.
  • E6. Patient under guardianship or curatorship or placed under the protection of justice.
  • E7. Pregnant and/or nursing patient.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Clinical-biological cohortCytobrush sampleA clinical-biological cohort of 30 patients with epidermoid carcinomas of the oral cavity. Blood sample and cytobrush sample at inclusion and before anti-cancer treatment.
Clinical-biological cohortBlood samplingA clinical-biological cohort of 30 patients with epidermoid carcinomas of the oral cavity. Blood sample and cytobrush sample at inclusion and before anti-cancer treatment.
Primary Outcome Measures
NameTimeMethod
Identify somatic mutations of the driver genes from healthy oral mucosa from patients with epidermoid carcinomas of the upper aerodigestive tract1 year

Identified mutations described by type and number

Secondary Outcome Measures
NameTimeMethod
Correlation between tobacco consumption and the total number of somatic mutations detected in the healthy oral mucosa in patients with OSCC1 year

Correlation between tobacco consumption and total number of somatic mutations detected

Correlation between alcohol consumption and the total number of somatic mutations detected in the healthy oral mucosa in patients with OSCC1 year

Correlation between alcohol consumption and total number of somatic mutations

Trial Locations

Locations (1)

Centre Léon Bérard

🇫🇷

Lyon, France

© Copyright 2024. All Rights Reserved by MedPath